Treffer 1 - 6 von 6 für Suche 'Sperone, Alexandra', Suchdauer: 0,53s Treffer weiter einschränken
  1. 1
    ATP1A1 is a promising new target for melanoma treatment and can be inhibited by its physiological ligand bufalin to restore targeted therapy efficacy

    ATP1A1 is a promising new target for melanoma treatment and can be inhibited by its physiological ligand bufalin to restore targeted therapy efficacy von Soumoy, Laura, Genbauffe, Aline, Mouchart, Lena, Sperone, Alexandra, Trelcat, Anne, Mukeba-Harchies, Léa, Wells, Mathilde, Blankert, Bertrand, Najem, Ahmad, Ghanem, Ghanem, Saussez, Sven, Journe, Fabrice

    Veröffentlicht in Cancer cell international

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  2. 2
    Additional file 5 of ATP1A1 is a promising new target for melanoma treatment and can be inhibited by its physiological ligand bufalin to restore targeted therapy efficacy

    Additional file 5 of ATP1A1 is a promising new target for melanoma treatment and can be inhibited by its physiological ligand bufalin to restore targeted therapy efficacy von Soumoy, Laura, Genbauffe, Aline, Mouchart, Lena, Sperone, Alexandra, Trelcat, Anne, Mukeba-Harchies, Léa, Wells, Mathilde, Blankert, Bertrand, Najem, Ahmad, Ghanem, Ghanem, Saussez, Sven, Journe, Fabrice

    Volltext bestellen
    Bild

    Zu den Favoriten
    Gespeichert in:
  3. 3
    Additional file 2 of ATP1A1 is a promising new target for melanoma treatment and can be inhibited by its physiological ligand bufalin to restore targeted therapy efficacy

    Additional file 2 of ATP1A1 is a promising new target for melanoma treatment and can be inhibited by its physiological ligand bufalin to restore targeted therapy efficacy von Soumoy, Laura, Genbauffe, Aline, Mouchart, Lena, Sperone, Alexandra, Trelcat, Anne, Mukeba-Harchies, Léa, Wells, Mathilde, Blankert, Bertrand, Najem, Ahmad, Ghanem, Ghanem, Saussez, Sven, Journe, Fabrice

    Volltext bestellen
    Bild

    Zu den Favoriten
    Gespeichert in:
  4. 4
    Additional file 1 of ATP1A1 is a promising new target for melanoma treatment and can be inhibited by its physiological ligand bufalin to restore targeted therapy efficacy

    Additional file 1 of ATP1A1 is a promising new target for melanoma treatment and can be inhibited by its physiological ligand bufalin to restore targeted therapy efficacy von Soumoy, Laura, Genbauffe, Aline, Mouchart, Lena, Sperone, Alexandra, Trelcat, Anne, Mukeba-Harchies, Léa, Wells, Mathilde, Blankert, Bertrand, Najem, Ahmad, Ghanem, Ghanem, Saussez, Sven, Journe, Fabrice

    Volltext bestellen
    Bild

    Zu den Favoriten
    Gespeichert in:
  5. 5
    Additional file 4 of ATP1A1 is a promising new target for melanoma treatment and can be inhibited by its physiological ligand bufalin to restore targeted therapy efficacy

    Additional file 4 of ATP1A1 is a promising new target for melanoma treatment and can be inhibited by its physiological ligand bufalin to restore targeted therapy efficacy von Soumoy, Laura, Genbauffe, Aline, Mouchart, Lena, Sperone, Alexandra, Trelcat, Anne, Mukeba-Harchies, Léa, Wells, Mathilde, Blankert, Bertrand, Najem, Ahmad, Ghanem, Ghanem, Saussez, Sven, Journe, Fabrice

    Volltext bestellen
    Bild

    Zu den Favoriten
    Gespeichert in:
  6. 6
    Additional file 3 of ATP1A1 is a promising new target for melanoma treatment and can be inhibited by its physiological ligand bufalin to restore targeted therapy efficacy

    Additional file 3 of ATP1A1 is a promising new target for melanoma treatment and can be inhibited by its physiological ligand bufalin to restore targeted therapy efficacy von Soumoy, Laura, Genbauffe, Aline, Mouchart, Lena, Sperone, Alexandra, Trelcat, Anne, Mukeba-Harchies, Léa, Wells, Mathilde, Blankert, Bertrand, Najem, Ahmad, Ghanem, Ghanem, Saussez, Sven, Journe, Fabrice

    Volltext bestellen
    Bild

    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: